Susquehanna International Group, LLP Alaunos Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$0.43 - $0.65 $19,780 - $29,900
46,000 Added 40.82%
158,700 $80,000
Q1 2023

May 16, 2023
SELL
$0.46 - $0.81 $27,508 - $48,438
-59,800 Reduced 34.67%
112,700 $71,000
Q4 2022

Feb 14, 2023
SELL
$0.5 - $261.0 $65,850 - $34.4 Million
-131,700 Reduced 43.29%
172,500 $112,000
Q3 2022

Nov 14, 2022
BUY
$1.04 - $322.5 $157,456 - $48.8 Million
151,400 Added 99.08%
304,200 $523,000

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $517M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email